XML 52 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Numerator:        
Income from continuing operations $ 102.3 $ 139.3 $ 239.5 $ 369.7
Less: dividends declared (28.7) (28.3) (84.7) (74.5)
Undistributed earnings $ 73.6 $ 111.0 $ 154.8 $ 295.2
Percent allocated to common shareholders 99.70% 99.70% 99.70% 99.70%
Undistributed earnings available to common shareholders $ 73.4 $ 110.7 $ 154.3 $ 294.3
Add: dividends declared on common stock, restricted share units and vested and deferred restricted and performance shares 28.4 28.2 84.3 74.3
Income from continuing operations attributable to common shares $ 101.8 $ 138.9 $ 238.6 $ 368.6
Denominator (in thousands):        
Basic weighted-average shares outstanding (in shares) 54,100,000 56,700,000 54,900,000 57,100,000
Effect of dilutive securities:        
Performance awards (in shares) 200,000 200,000 200,000 200,000
Stock options (in shares) 200,000 400,000 300,000 300,000
Denominator for diluted EPS: weighted-average shares outstanding (in shares) 54,500,000 57,300,000 55,400,000 57,600,000
Per share income from continuing operations attributable to common shares:        
Basic (in dollars per share) $ 1.88 $ 2.45 $ 4.35 $ 6.46
Diluted (in dollars per share) $ 1.87 $ 2.42 $ 4.31 $ 6.40
Basic weighted-average shares outstanding (in shares) 54,100,000 56,700,000 54,900,000 57,100,000
Basic weighted-average shares outstanding and unvested restricted shares expected to vest (in shares) 54,300,000 56,800,000 55,100,000 57,300,000
Percent allocated to common shareholders 99.70% 99.70% 99.70% 99.70%
Income (loss) from discontinued operations and net income        
(Loss) income from discontinued operations attributable to common shareholders for basic and diluted earnings per share $ 0.0 $ (1.4) $ 0.0 $ 0.5
Net income attributable to common shareholders for basic and diluted earnings per share $ 101.8 $ 137.5 $ 238.6 $ 369.1
Antidilutive stock options excluded from EPS calculation (in shares) 400,000 0 300,000 0